Last week Aeras and the Infectious Disease Research Institute (IDRI) announced the start of the Phase I trial of vaccine candidate ID93. he impact of such a new vaccine will have the potential to protect the health and save the lives of millions of people around the world, including the 8.8 million people who develop active TB and the 1.4 million people who die each year.
Fascinating evidence published this week has indicated that one day silk, the common material used for clothing, could help us reach more people with life-saving vaccines. This is because thestudy indicates proteins found in silk could remove the need for vaccines to be kept at low temperatures and therefore transported through cold chains.
To bring attention to the need for increased investment in research and development for tuberculosis, ACTION, in partnership with TB Alliance and Aeras, is hosting a free, public session at the 2012 International AIDS Conference, called Saving Lives Through Research & Development: Developing Better Technologies to Address TB/HIV. Global Village’s TB-HIV Networking Zone, Exhibit Hall C, Booth #64, International AIDS Conference, Washington Conference Center, Washington, D.C.
The message from global health heroes at both the RESULTS International Conference and the International AIDS Conference (IAC), overlapping today in Washington, D.C. is clear: the progress on HIV/AIDS has been spurred in a meaningful way by the loud voices of strong advocates. "We need advocates to push us very hard."
As a swing dancer, I can definitely appreciate the 1920s; its fashion, music, and dancing are brilliant, and I’m glad they’ve stuck around. But 1920s medicine? Not so much. One of the most distressing facts in the current fight against tuberculosis (TB) is that no new vaccines have been invented since this period. The current vaccine, BCG, was developed back when Jay Gatsby was sipping champagne and only offers limited protection against the most common forms of pulmonary TB.
As a public health graduate student, I jump at any chance I have to get involved in my future field. The other day, I was given an opportunity to visit Aeras and tour their facility. With an academic background that is strictly social science, I was initially intimidated by the hard science that would soon be thrown my way via chemical compounds, acronyms, and scientific processes used to develop Tuberculosis vaccines. But then I thought to myself, Tuberculosis vaccines! How can I pass on an opportunity to meet with people that could potentially save millions of lives (approximately 1.4 million per year, according to Aeras)?